|
Welcome to Alnis BioSciences. Alnis BioSciences has expertise in the fabrication of nanoparticles and the use of these particles for life science applications. Alnis is currently developing proprietary MagNaGel™ nanoparticles that combine diagnostic, drug and device capabilities to better detect, characterize and treat cancer. MagNaGel nanoparticles approximate the size and tumor-targeting capabilities of monoclonal antibodies. The nanoparticles are also comprised of magnetic crystals which enable several functions, including the use of MRI to track nanoparticles in the body.  © Copyright 2007, Alnis BioSciences. All rights reserved. |
|